Ibrexafungerp

From WikiMD's Food, Medicine & Wellness Encyclopedia

Ibrexafungerp

What is Ibrexafungerp?[edit | edit source]

Ibrexafungerp (BREXAFEMME), available as an oral tablet, contains ibrexafungerp citrate, a triterpenoid antifungal agent.

What are the uses of this medicine?[edit | edit source]

Ibrexafungerp (BREXAFEMME) is a triterpenoid antifungal indicated for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis

How does Ibrexafungerp work?[edit | edit source]

  • Ibrexafungerp is a triterpenoid antifungal drug.
  • Ibrexafungerp inhibits glucan synthase, an enzyme involved in the formation of 1,3-β-D-glucan, an essential component of the fungal cell wall.
  • Ibrexafungerp has concentration-dependent fungicidal activity against Candida species as measured by time kill studies.
  • Ibrexafungerp retains in vitro antifungal activity when tested at pH 4.5 (the normal vaginal pH).
  • Resistance The potential for resistance to ibrexafungerp has been evaluated in vitro and is associated with mutations of the fks-2 gene; the clinical relevance of these findings is unknown.

Who Should Not Use this medicine?[edit | edit source]

  • Pregnancy
  • Hypersensitivity to ibrexafungerp

Is Ibrexafungerp FDA approved?[edit | edit source]

Yes, in June of 2021, under brand name BREXAFEMME

How should Ibrexafungerp be used?[edit | edit source]

  • The recommended dosage of Ibrexafungerp in adult and post-menarchal pediatric females is 300 mg (two tablets of 150 mg) twice a day for one day, for a total treatment dosage of 600 mg.
  • Ibrexafungerp may be taken with or without food.
  • Prior to initiating treatment, verify pregnancy status in females of reproductive potential.

What are the dosage forms and brand names of this medicine?[edit | edit source]

Tablets: 150 mg of ibrexafungerp

What side effects can this medication cause?[edit | edit source]

The most frequent adverse reactions (≥ 2%) reported with ibrexafungerp in clinical trials of vulvovaginal candidiasis treatment were:

What drug interactions can Ibrexafungerp cause?[edit | edit source]

  • Simultaneous use of strong CYP3A inhibitors increases the exposure of ibrexafungerp.
  • Reduce Ibrexafungerp dose with concomitant use of a strong CYP3A inhibitor to 150 mg twice daily for one day.
  • Simultaneous use of strong and moderate CYP3A inducers may significantly reduce the exposure of ibrexafungerp.
  • Avoid simultaneous administration of Ibrexafungerp with strong or moderate CYP3A inducers

What special precautions should I follow?[edit | edit source]

  • Risk of Fetal Toxicity: May cause fetal harm based on animal studies.
  • Advise females of reproductive potential to use effective contraception during treatment

What to do in case of emergency/overdose?[edit | edit source]

  • In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

There is no experience with overdosage of Ibrexafungerp. There is no specific antidote for ibrexafungerp. Treatment should be supportive with appropriate monitoring

Can Ibrexafungerp be used in pregnancy?[edit | edit source]

No. Based on findings from animal studies, BREXAFEMME use is contraindicated in pregnancy because it may cause fetal harm

Can Ibrexafungerp be used in children?[edit | edit source]

Not studied

What should I know about storage and disposal of this medication?[edit | edit source]

  • Store BREXAFEMME at room temperature between 68°F to 77°F (20°C to 25°C).
  • BREXAFEMME is supplied in child resistant packaging.
  • Keep BREXAFEMME and all medicines out of reach of children.

What are the active and inactive ingredients in this medicine?[edit | edit source]

  • Active ingredient: ibrexafungerp

Inactive ingredients

  • Tablet core:butylated hydroxyanisole, colloidal silicon dioxide, crospovidone, magnesium stearate, mannitol, and microcrystalline cellulose.
  • Tablet film coating: FD&C Blue #2, FD&C Red #40, hydroxypropyl cellulose, hydroxypropylmethyl cellulose 2910, talc and titanium dioxide.
Ibrexafungerp Resources
Doctor showing form.jpg


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD